| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $18,810,856 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM133600 | Repetitive sequences drive genome variation and plasticity | 000 | 7 | NIH | 1/7/2026 | $463,652 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM156397 | UBIQUITIN-PROTEASOME PATHWAY in HUMAN DISEASE | 000 | 2 | NIH | 1/15/2026 | $424,450 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR055607 | Notch signaling and Bone Fracture Healing | 000 | 14 | NIH | 1/14/2026 | $483,019 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS131661 | Transient Receptor Potential Melastatin 2 (TRPM2) in Ischemic Stroke | 000 | 3 | NIH | 12/23/2025 | $406,904 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K01DK133627 | Examining the role of locus coeruleus glucagon-like peptide-1 receptors in feeding behavior | 001 | 4 | NIH | 1/16/2026 | $150,930 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01MH085927 | Synaptic function of BK channel-interacting proteins | 000 | 15 | NIH | 1/6/2026 | $551,722 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AI196752 | RpoS-independent gene regulation by the Borrelia burgdorferi Fur ortholog BosR | 000 | 1 | NIH | 2/10/2026 | $457,875 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 000 | 4 | NIH | 11/26/2025 | $416,250 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HD112424 | Dysregulation of Endometrial Invasibility Proximal to Uterine Scar as a Mechanism of Placenta Accreta | 000 | 3 | NIH | 3/4/2026 | $479,620 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30GM163345 | Investigating how splicing factor homeostasis shapes transcriptomes in pluripotency and differentiation | 001 | 1 | NIH | 2/1/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA274959 | Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancer | 000 | 4 | NIH | 3/5/2026 | $627,562 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK132059 | Importance of cell-matrix interactions in kidney repair after acute kidney injury | 000 | 4 | NIH | 12/19/2025 | $493,382 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21NS142499 | Transposon-mediated genetic manipulation of OPCs to study their role in synapse formation | 000 | 1 | NIH | 3/16/2026 | $471,861 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162332 | Cracking the tubulin code of cell migration | 000 | 1 | NIH | 2/12/2026 | $457,875 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 000 | 3 | NIH | 2/12/2026 | $507,162 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 5 | NIH | 12/12/2025 | $387,625 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK134475 | Novel mechanisms of kidney inflammation and fibrosis | 000 | 4 | NIH | 12/17/2025 | $523,599 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 000 | 4 | NIH | 12/17/2025 | $632,825 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DA051671 | Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults | 000 | 5 | NIH | 2/19/2026 | $677,178 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI187147 | The role of unanchored ubiquitin chains in non-canonical inflammasome signaling | 000 | 1 | NIH | 2/1/2026 | $523,037 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AR085243 | Metabolomic Signatures of Alcohol Consumption and Risk of Knee Osteoarthritis | 000 | 2 | NIH | 2/6/2026 | $162,141 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30GM163345 | Investigating how splicing factor homeostasis shapes transcriptomes in pluripotency and differentiation | 000 | 1 | NIH | 2/1/2026 | $46,415 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084992 | Role of NOTCH2 in Articular Inflammation | 000 | 2 | NIH | 2/12/2026 | $361,222 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 000 | 4 | NIH | 2/13/2026 | $497,480 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162154 | Mechanisms of translation response to stress | 000 | 1 | NIH | 2/13/2026 | $457,875 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K99DA062786 | Mechanisms of Action of Peer Recovery Support for People Receiving Opioid Use Disorder Treatment | 000 | 1 | NIH | 2/3/2026 | $191,700 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 000 | 4 | NIH | 1/31/2026 | $392,876 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL177653 | Pathogenicity and pathophysiology assessments of sarcomere gene variants identified in the clinic | 000 | 2 | NIH | 2/18/2026 | $578,082 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 000 | 4 | NIH | 1/30/2026 | $454,846 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162319 | Investigating Dead Cell-Phagocyte Interaction at the Phagosomal Interface to Decode Death-Associated Responses | 000 | 1 | NIH | 3/18/2026 | $423,352 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM156397 | UBIQUITIN-PROTEASOME PATHWAY in HUMAN DISEASE | 001 | 2 | NIH | 3/19/2026 | $47,161 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30GM163345 | Investigating how splicing factor homeostasis shapes transcriptomes in pluripotency and differentiation | 002 | 1 | NIH | 3/18/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM128635 | Mechanisms of coordinate gene regulation by transcription factors | 001 | 8 | NIH | 3/11/2026 | $44,955 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM133600 | Repetitive sequences drive genome variation and plasticity | 001 | 7 | NIH | 3/19/2026 | $51,517 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01EB023607 | Asymmetric CRISPR Approach for Nucleic Acid Quantification | 000 | 6 | NIH | 3/30/2026 | $643,849 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA282775 | How RNA binding proteins control effector T cell responses | 000 | 3 | NIH | 3/31/2026 | $488,604 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR080131 | The role of Dot1L activity in chondrogenic differentiation | 000 | 5 | NIH | 3/31/2026 | $392,462 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI167886 | Bacterial Reprogramming that Contributes to Antibiotic Persistence toward Topoisomerase Inhibitors | 000 | 3 | NIH | 3/30/2026 | $479,558 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | T32AA007290 | Postdoctoral Training Program in Alcohol Studies | 000 | 43 | NIH | 3/20/2026 | $176,640 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AR078352 | Roles of the superficial zone in mature articular cartilage | 000 | 5 | NIH | 3/25/2026 | $224,101 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081659 | Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteins | 000 | 5 | NIH | 3/25/2026 | $563,890 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 001 | 3 | NIH | 3/24/2026 | $16,015 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31HL178225 | TRPM7-mediated macrophage signaling in atherosclerosis | 000 | 2 | NIH | 3/25/2026 | $45,686 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM138319 | Coordination of alternative exon and 3'UTR choices in mRNAs | 001 | 8 | NIH | 4/3/2026 | $457,875 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21NS142751 | Molecular mechanism of the synapse organizer C1QL3 | 000 | 2 | NIH | 3/31/2026 | $208,125 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 3 | NIH | 1/20/2026 | $677,618 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K99HL179383 | Role of TRPM7-Mediated Signaling in Vascular Remodeling in Abdominal Aortic Aneurysm | 000 | 1 | NIH | 3/27/2026 | $130,275 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084284 | Cellular Therapy for Osteogenesis Imperfecta | 000 | 2 | NIH | 3/10/2026 | $341,258 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS131327 | Role of CD8 T cell-mediated Pathology in Globoid Cell Leukodystrophy | 000 | 4 | NIH | 2/27/2026 | $504,601 |
|
